1-20 of 52
Li Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Standard-Dose Versus Fixed-Dose Rituximab for Non-Malignant, Immune-Mediated Hematologic Disorders

Raj S. Kasthuri, Ryan Kemper, Brittany Holshouser, Elizabeth Powell, Allison B Carroll, Sheh-Li Chen, Daniel Crona, Lee Ann Jones
Journal: Blood
Blood (2024) 144 (Supplement 1): 1237.
https://doi.org/10.1182/blood-2024-210540
Published: 2024
Journal Articles

Gilteritinib Results in Higher Remission and Transplant Rates Than Midostaurin but Does Not Increase the Post-Induction Mutational MRD Negative Rate: Results of the Phase 2 Randomized Precog 0905 Study in Newly Diagnosed FLT3 Mutated AML

Selina Luger, Li Chen, Keith W. Pratz, Sanam Loghavi, Alexander E. Perl, Jessica K. Altman, Robert L. Redner, Amir T. Fathi, Ayman Qasrawi, Adam S. Asch, Deepa Jeyakumar, James M. Foran, Mithun V Shah, Jonathan E Kolitz, Ellin Berman, Lindsay Wilde, Sameem Abedin, Vamsi K. Kota, Krishna Gundabolu, Kristen M. O'Dwyer, Emily K Curran, Ashwin Kishtagari, Kelly Ross, Zhuoxin Sun, Mark R. Litzow
Journal: Blood
Blood (2024) 144 (Supplement 1): 221.
https://doi.org/10.1182/blood-2024-201595
Published: 2024
Journal Articles

Prognostic Implications of KMT2A Rearrangements and Partial Tandem Duplications in AML: Outcomes and the Role of Allogeneic Hematopoietic Cell Transplantation

Li Chen, Yongmei Zhu, Lingling Zhao, Jianfeng Li, Ran An, Zhiyin Liu, Xiaoqian Xu, Sujiang Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 4291.
https://doi.org/10.1182/blood-2024-200787
Published: 2024
Journal Articles

Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study

Fu Cheng Cheng, Song Jin, Junling Zhuang, Xin Zhou, Fan Zhou, Yuhua Li, Kaiyang Ding, Ting Niu, Wenming Chen, Baijun Fang, Li-Li Chen, Rong Fu, Hao Zhang, Jiaping Fu, Xiuju Wang, Sha Liu, Lin Li, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 6970.
https://doi.org/10.1182/blood-2024-204366
Published: 2024
Journal Articles

Comprehensive Clinical and Molecular Characterization Reveals Rara As the Most Frequent Torque Teno Mini Virus Insertion Site and Defines a Distinct Ttmv::Rara Driven APL-like Leukemia Subtype

Shu Sun, Yongjing Liu, Qing-Yu Xu, Xiaosu Zhou, Lijun Wen, Li Chen, Jiaqi Chen, Huili Wang, Xue Chen, Jiacheng Lou, Huyong Zheng, Yangyang Xie, Linya Wang, Futian Ma, Lihua Yang, Xianjing Wang, Wen Gao, Yin Wu, Leping Zhang, Shuhong Shen, Suning Chen, Kankan Wang, Hongxing Liu, Jinyan Huang, Hong-Hu Zhu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1547.
https://doi.org/10.1182/blood-2024-202323
Published: 2024
Journal Articles

The Evolution of Treatments and Outcomes for Real-World Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in a Chinese National Medical Center: Over 10 Years of Experience with 370 Patients

Ran An, Wen Jin, Xiangqin Weng, Kankan Wang, Sujiang Zhang, Li Chen, Jianqing Mi
Journal: Blood
Blood (2024) 144 (Supplement 1): 6790.
https://doi.org/10.1182/blood-2024-207401
Published: 2024
Journal Articles

Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide

Li Chen, Hongming Zhu, Fangyi Dong, Yan Li, Qifa Liu, Yu Hu, Yicheng Zhang, Jie Jin, Jianda Hu, Ting Liu, Depei Wu, Jieping Chen, Yongrong Lai, Jianxiang Wang, Juan Li, Jianyong Li, Xin Du, Xin Wang, Mingzhen Yang, Jinsong Yan, Guifang Ouyang, Li Liu, Ming Hou, Xiaojun Huang, Wen Jin, Yongmei Zhu, Jian Li, Kankan Wang, Zhu Chen, Sai-Juan Chen, Junmin Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 2946.
https://doi.org/10.1182/blood-2023-184433
Published: 2023
Journal Articles

Real-World Experience of Ropeginterferon-Alfa Treatment of PV and ET - Two Centers Experience

Tsewang Tashi, Brandi N. Reeves, Soo Jin Kim, Hyewon Jeong, Sheh-Li Chen, Brynn Parsegov, Josef T. Prchal
Journal: Blood
Blood (2023) 142 (Supplement 1): 6397.
https://doi.org/10.1182/blood-2023-191268
Published: 2023
Journal Articles

Older Adults with Acute Myeloid Leukemia (AML) Experience Improvement in Health-Related Quality of Life (HRQoL) Scores with Intensive Therapy: Prospective Study from ECOG-ACRIN (EA) E2906 Phase 3 Trial

James M. Foran, Li Chen, Selina M Luger, Zhuoxin Sun, Heidi Klepin, David F. Claxton, Hillard M. Lazarus, Jacob M. Rowe, Jessica K. Altman, Aref Al-Kali, Hong Zheng, Keith W Pratz, Edward R. Broun, Bayard L Powell, Kristen M. O'Dwyer, Yishai Ofran, John E. Godwin, Mark R. Litzow, Martin S. Tallman, Lynne Wagner
Journal: Blood
Blood (2023) 142 (Supplement 1): 594.
https://doi.org/10.1182/blood-2023-189734
Published: 2023
Journal Articles

Ropegiterferon Alfa-2b-Njft for Treatment Myeloproliferative Neoplasms: A Single Institution Experience

Callie Berkowitz, Sheh-Li Chen, Brandi Reeves
Journal: Blood
Blood (2022) 140 (Supplement 1): 12254–12255.
https://doi.org/10.1182/blood-2022-164733
Published: 2022
Journal Articles

Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia

Huan Song, Yabin Liu, Yun Tan, Yi Zhang, Wen Jin, Li Chen, Shishuang Wu, Jinsong Yan, Junmin Li, Zhu Chen, Saijuan Chen, Kankan Wang
Journal: Blood
Blood (2022) 140 (10): 1132–1144.
https://doi.org/10.1182/blood.2021014945
Published: 2022
Includes: Supplemental data
Journal Articles

Rituximab Monotherapy Is Effective for Inhibitor Eradication with Concomitant Porcine Factor VIII Followed By Emicizumab for Bleed Control in Acquired Hemophilia a

Patrick Ellsworth, Sheh-Li Chen, Christopher Wang, Nigel S Key, Alice Ma
Journal: Blood
Blood (2021) 138 (Supplement 1): 348.
https://doi.org/10.1182/blood-2021-154207
Published: 2021
Journal Articles

Incidence and Time Course of Neutropenia in Patients Treated with Rituximab-Based Therapy for Non-Malignant Immune-Mediated Hematologic Diseases

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Anqi Zhu, MS, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 390.
https://doi.org/10.1182/blood-2019-121343
Published: 2019
Journal Articles

Enhancing Anti-Tumor Immunity and Responses to Immune Checkpoint Blockade By Suppressing Interleukin-10 in Chronic Lymphocytic Leukemia

Jacqueline R. Rivas, PhDBS, Sara S. Alhakeem, PhD, Joseph M. Eckenrode, PhD, Yinan Zhang, PhD, James P. Collard, BS, Gerhard C. Hildebrandt, MD, Roger A. Fleischman, MD PhD, Li Chen, PhD, Jon S. Thorson, PhD, Markos Leggas, PhD, Subbarao Bondada, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5486.
https://doi.org/10.1182/blood-2019-127178
Published: 2019
Journal Articles

In silico Prediction Followed By in Vitro validation Identifies the Survivin Inhibitor YM155 As a Potent Secondary Drug Against Pi-Resistant Myeloma

Harish Kumar, PhD, Ujjal Kumar Mukherjee, PhD, Li Chen, PhD, Amit Kumar Mitra, PhD MSc, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5543.
https://doi.org/10.1182/blood-2019-131923
Published: 2019
Journal Articles

Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Anqi Zhu, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Stephan Moll, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 792.
https://doi.org/10.1182/blood-2019-121340
Published: 2019
Journal Articles

Recombinant Porcine FVIII in Acquired Hemophilia: Decreased Product Usage When Used Upfront, Non-Utility of Baseline Porcine Bethesda Titer, and Confirmation of Dosing Algorithm

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Nigel S. Key, MBChB, FRCP, Raj S. Kasthuri, MD, Micah J. Mooberry, MD, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2474.
https://doi.org/10.1182/blood-2018-99-118839
Published: 2018
Journal Articles

Secdrug: A Computational Method for Discovering Novel Secondary Drug Combinations Using Large-Scale Pharmacogenomics Databases

Li Chen, PhD, Ujjal Kumar Mukherjee, PhD, Emily Rankine, Brian G. Van Ness, PhD, Amit Kumar Mitra, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4473.
https://doi.org/10.1182/blood-2018-99-117653
Published: 2018
Journal Articles

Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Yasmina L. Abajas, MD, Stephan Moll, MD, Nigel S. Key, MBChB, FRCP, Alice D. Ma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1202.
https://doi.org/10.1182/blood-2018-99-119196
Published: 2018
Journal Articles

Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function

Steven D. Scoville, Ansel P. Nalin, Luxi Chen, Li Chen, Michael H. Zhang, Kathleen McConnell, Susana Beceiro Casas, Gabrielle Ernst, Abd Al-Rahman Traboulsi, Naima Hashi, Monica Williams, Xiaoli Zhang, Tiffany Hughes, Anjali Mishra, Don M. Benson, Jennifer N. Saultz, Jianhua Yu, Aharon G. Freud, Michael A. Caligiuri, Bethany L. Mundy-Bosse
Journal: Blood
Blood (2018) 132 (17): 1792–1804.
https://doi.org/10.1182/blood-2018-03-838474
Published: 2018
Includes: Supplemental data